The Yale Alzheimer’s Disease Research Center in New Haven, Connecticut, will begin recruiting volunteers for a worldwide prevention study. The Alzheimer’s Prevention Initiative Generation Program has created two studies that focus on adults, ages 55 to 75.
The goal is to see if an experimental drug can help to slow down or stop symptoms of late-onset Alzheimer’s disease.
Yale will be one of 80 sites in the United States and one of 180 sites worldwide that will be working on these studies. They are currently working with the GeneMatch program to find volunteers for the first study, and will find volunteers for the second study in the near future.
Every three seconds, a new case of Alzheimer’s disease or another form of dementia is diagnosed. In Connecticut, more than 74,000 people 65 and older have been diagnosed with Alzheimer’s disease, and that number is projected to grow to 91,000 by 2025, if no treatment is developed.
To be eligible for the study, you must be between the ages of 55 and 75, and have not been diagnosed with cognitive impairment.